| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DIABETES.51.2007.S109 |
| P698 | PubMed publication ID | 11815468 |
| P50 | author | Riccardo C Bonadonna | Q42925893 |
| P2093 | author name string | Piero Marchetti | |
| Stefano Del Prato | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | S109-16 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Phasic insulin release and metabolic regulation in type 2 diabetes | |
| P478 | volume | 51 Suppl 1 |
| Q37107776 | A 3-year follow-up study of β-cell function in patients with early-onset type 2 diabetes |
| Q37399580 | A chemical-genetic approach to study G protein regulation of beta cell function in vivo. |
| Q46775808 | A mathematical model of the impact of insulin secretion dynamics on selective hepatic insulin resistance |
| Q42106674 | A minimal C-peptide sampling method to capture peak and total prehepatic insulin secretion in model-based experimental insulin sensitivity studies |
| Q42944808 | Associated factors of impaired fasting glucose in some Korean rural adults |
| Q33870065 | BAIAP3, a C2 domain-containing Munc13 protein, controls the fate of dense-core vesicles in neuroendocrine cells |
| Q21203064 | Beneficial effects of green tea: a literature review |
| Q37215420 | Beta-cell failure in type 2 diabetes mellitus |
| Q30854105 | Ca2+ channel clustering with insulin-containing granules is disturbed in type 2 diabetes |
| Q28594910 | CaV2.3 calcium channels control second-phase insulin release |
| Q91809508 | Calcium Signaling in ß-cell Physiology and Pathology: A Revisit |
| Q36109246 | Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass |
| Q33610676 | Changing the treatment paradigm for type 2 diabetes |
| Q89713538 | Clinical utility of 30-min plasma glucose for prediction of type 2 diabetes among people with prediabetes: Ancillary analysis of the diabetes community lifestyle improvement program |
| Q36599383 | Critical metabolic roles of β-cell M3 muscarinic acetylcholine receptors |
| Q27342218 | Cytoskeletal dependence of insulin granule movement dynamics in INS-1 beta-cells in response to glucose |
| Q36765258 | Diabetes management using modern information and communication technologies and new care models |
| Q38762377 | Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes. |
| Q89461569 | Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals |
| Q37668432 | Early impairment of skeletal muscle endothelial glycocalyx barrier properties in diet-induced obesity in mice. |
| Q37302061 | Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol |
| Q37379205 | Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice |
| Q38200338 | Employing novel animal models in the design of clinically efficacious GPCR ligands |
| Q45198666 | Ethnic differences in beta cell adaptation to insulin resistance in obese children and adolescents |
| Q33844995 | Evaluation of Classifier Performance for Multiclass Phenotype Discrimination in Untargeted Metabolomics |
| Q33567322 | Glucagon-like peptide 1 receptor plays a critical role in geniposide-regulated insulin secretion in INS-1 cells |
| Q37189312 | Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents |
| Q84590951 | Glycemic variability in gestational diabetes mellitus and its association with β cell function |
| Q46565432 | Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins |
| Q37251086 | High glucose represses β-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor γ signaling |
| Q50198621 | Influencing factors of glycemic variability in hospitalized type 2 diabetes patients with insulin therapy: A Strobe-compliant article. |
| Q42932553 | Insulin Secretory Granules Enter a Highly Calcium‐Sensitive State following Palmitate‐Induced Dissociation from Calcium Channels: A Theoretical Study |
| Q39791339 | Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais |
| Q45045696 | Insulin resistance elicited in postpubertal primate offspring deprived of estrogen in utero |
| Q35184288 | Intermediate metabolism in normal pregnancy and in gestational diabetes. |
| Q34543003 | Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes--a study in both people with type 2 diabetes and healthy subjects |
| Q84499882 | Lost in translation |
| Q36511675 | Lysosomal integral membrane protein Sidt2 plays a vital role in insulin secretion |
| Q89051430 | Metabolic activation-driven mitochondrial hyperpolarization predicts insulin secretion in human pancreatic beta-cells |
| Q37182979 | Newcomer insulin secretory granules as a highly calcium-sensitive pool |
| Q34625376 | Novel insights into the function of β-cell M3 muscarinic acetylcholine receptors: therapeutic implications |
| Q35896348 | Obesity, bariatric surgery and type 2 diabetes--a systematic review |
| Q55420946 | Oral Glucose Tolerance Test Glucose Peak Time Is Most Predictive of Prediabetes and Hepatic Steatosis in Obese Girls. |
| Q53954047 | PI4KIIα regulates insulin secretion and glucose homeostasis via a PKD-dependent pathway. |
| Q37832150 | Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes |
| Q38429701 | Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes |
| Q37207848 | Population pharmacodynamic modeling of hyperglycemic clamp and meal tolerance tests in patients with type 2 diabetes mellitus |
| Q46129542 | Positive Feedback Amplifies the Response of Mitochondrial Membrane Potential to Glucose Concentration in Clonal Pancreatic Beta Cells |
| Q58876504 | Prediabetes in youth - mechanisms and biomarkers |
| Q34235559 | Proinsulin atypical maturation and disposal induces extensive defects in mouse Ins2+/Akita β-cells |
| Q33883131 | Reduced first-phase insulin secretion increases postprandial lipidemia in subjects with impaired glucose tolerance |
| Q37370688 | Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice |
| Q28550796 | Rosuvastatin Treatment Affects Both Basal and Glucose-Induced Insulin Secretion in INS-1 832/13 Cells |
| Q42427575 | Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice |
| Q36209905 | Statistical Frailty Modeling for Quantitative Analysis of Exocytotic Events Recorded by Live Cell Imaging: Rapid Release of Insulin-Containing Granules Is Impaired in Human Diabetic β-cells |
| Q33630394 | The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes. |
| Q39952371 | The thermic response to food is related to sensitivity to adrenaline in a group at risk for the development of type II diabetes |
| Q36947018 | beta-cell function and anti-diabetic pharmacotherapy |
| Q35183950 | β cell death and dysfunction during type 1 diabetes development in at-risk individuals |
Search more.